Picture of CEL AI logo

CLAI — CEL AI News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Grant of Share Options

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220817:nRSQ2337Wa&default-theme=true

RNS Number : 2337W  Cellular Goods PLC  17 August 2022

Press release

 

17 August 2022

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

 

Grant of Share Options

 

 

Cellular Goods (LSE: CBX), a UK-based wellness company providing premium
consumer products formulated with lab-produced cannabinoids, announces that
the Board has granted an award of a total of 2,350,000 ordinary shares of
£0.001 each in the Company ("Options") to the following individuals.

 

Nikhil Vijayan, Chief Supply Chain Officer, who joined the Company in March
2022, has been granted Options over 2,000,000 ordinary shares with the Options
priced at 6.35p per ordinary share. Philippa Bealey, Marketing Director, who
joined the Company in June 2022, has been granted Options over 350,000
ordinary shares with the Options priced at 4.1p per ordinary share.

 

The exercise prices were determined based on the spot price for Cellular
Goods' shares at the time Mr Vijayan and Ms Bealey accepted their respective
employment offers. The Options will vest over three years, with a one-year
cliff, so that 12/36(th) of the shares vest on the one-year anniversary of the
start date, and thereafter 1/36(th) of the shares vest each month, so that
100% of the shares will have vested three years from the start date.

 

The grant of the Options is designed to motivate and retain Mr Vijayan and Ms
Bealey as key employees of the Company and align their interests with those of
the Company's shareholders.

 

For further information please contact:

 

 Cellular Goods
 Anna Chokina                                                               via Tancredi +44 207 887 7633

 Chief Executive

 Investor Relations                                                         ir@cellular-goods.com
 Tennyson Securities
 Corporate Broker

 Peter Krens                                                                +44 207 186 9030
 Novum Securities
 Corporate Broker

 Colin Rowbury

 Jon Belliss                                                                +44 207 399 9427
 Tancredi Intelligent Communication
 Media Relations

 Helen Humphrey                                                             +44 744 922 6720

 Gabriela Amaya Garcia                                                      +44 791 503 5294

 Charlie Hobbs                                                              +44 789 755 7112

 cellulargoods@tancredigroup.com (mailto:cellulargoods@tancredigroup.com)

 

 

Note to editors

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products
based on lab-made cannabinoids. It was established in August 2018 to develop
efficacy-led and research-backed cannabinoid-powered wellness products. The
initial focus is on three product verticals: Function Better, Feel Better and
Look Better. These three verticals encompass Cellular Goods' premium CBG
skincare and CBD ingestible and topical athletic recovery products, with the
first products launched in December 2021. The Company's shares are listed on
the main market of the London Stock Exchange. www.cellular-goods.com
(http://www.cellular-goods.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEPFMFTMTIBBIT

Recent news on CEL AI

See all news